Peptide record

TPDB39132

VV-H7 VV-hemorphin 7 VV-hemorphin-7 ACE inhibitors Antihypertensive Blood-Brain Barrier Neuropeptide Toxicity standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB39132
VV-H7 VV-hemorphin 7 VV-hemorphin-7
ACE inhibitors Antihypertensive Blood-Brain Barrier Neuropeptide Toxicity
Cardiometabolic peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides Neuroactive peptides
Peptipedia AHTPDB AHTpin B3Pred BBPpredict
standard
No
A 9-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, Blood-Brain Barrier, and other sources) peptide sequence curated from Peptipedia, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
Sequence
VVYPWTQRF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C59H82N14O13
ANDCEGHILKMS
V
1195.39
9.88
1
0
5
+1
1.09
-0.144
64.44
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
6990
5.85
3
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
1
Q
0
G
0
H
0
I
0
L
0
K
0
M
1
F
1
P
0
S
1
T
1
W
1
Y
2
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 1 P: 1 S: 0 T: 1 W: 1 Y: 1 V: 2
Chemical Descriptors
9 reviewed residue count
C59H82N14O13 sequence-only estimate (linear, free termini)
1195.39 sequence-only estimate (linear, free termini)
9.88 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
1.09 sequence-only estimate (linear, free termini)
-0.144 sequence-only estimate (linear, free termini)
1195.3651 Activity
Linear Activity
1194.6167 Activity
Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
34.30 µM
Inhibitor of Angiotensin-converting enzyme (EC 3.4.15.1) (MEROPS ID: M02-001).
ACE inhibitor
ah

Source & Reference

NA
Zhao Q., Sannier F., Garreau I., Guillochon, Piot J. M.
Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins isolated from peptic bovine hydrolysate. Biochem. Biophys. Res. Commun., 204, 216-223, 1994
1994
Journal

Other

9
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CC3=C[N](C4=C3C=CC=C4)[H])C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)O InChI=1S/C59H82N14O13/c1-31(2)47(61)54(81)71-48(32(3)4)55(82)69-43(27-35-19-21-37(75)22-20-35)57(84)73-26-12-18-45(73)53(80)68-42(29-36-30-65-39-16-10-9-15-38(36)39)52(79)72-49(33(5)74)56(83)67-41(23-24-46(60)76)51(78)66-40(17-11-25-64-59(62)63)50(77)70-44(58(85)86)28-34-13-7-6-8-14-34/h6-10,13-16,19-22,30-33,40-45,47-49,65,74-75H,11-12,17-18,23-29,61H2,1-5H3,(H2,60,76)(H,66,78)(H,67,83)(H,68,80)(H,69,82)(H,70,77)(H,71,81)(H,72,79)(H,85,86)(H4,62,63,64)/t33-,40+,41+,42+,43+,44+,45+,47+,48+,49+/m1/s1 InChIKey: FFBBHLKDMHCFTH-AKYHLAPZSA-N Opioid peptide according to the BIOPEP database of bioactive peptides (ID 2570) PepBank database Bitter peptide according to the BIOPEP database of sensory peptides and amino acids (ID 404)
Evidence 2 Activity

Activity

IC50
Antihypertensive
34.30 µM
Inhibitor of Angiotensin-converting enzyme (EC 3.4.15.1) (MEROPS ID: M02-001).
ACE inhibitor
ah

Source & Reference

AHTPDB
Zhao Q., Sannier F., Garreau I., Guillochon, Piot J. M.
Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins isolated from peptic bovine hydrolysate. Biochem. Biophys. Res. Commun., 204, 216-223, 1994
1994
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
9
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CC3=C[N](C4=C3C=CC=C4)[H])C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)O InChI=1S/C59H82N14O13/c1-31(2)47(61)54(81)71-48(32(3)4)55(82)69-43(27-35-19-21-37(75)22-20-35)57(84)73-26-12-18-45(73)53(80)68-42(29-36-30-65-39-16-10-9-15-38(36)39)52(79)72-49(33(5)74)56(83)67-41(23-24-46(60)76)51(78)66-40(17-11-25-64-59(62)63)50(77)70-44(58(85)86)28-34-13-7-6-8-14-34/h6-10,13-16,19-22,30-33,40-45,47-49,65,74-75H,11-12,17-18,23-29,61H2,1-5H3,(H2,60,76)(H,66,78)(H,67,83)(H,68,80)(H,69,82)(H,70,77)(H,71,81)(H,72,79)(H,85,86)(H4,62,63,64)/t33-,40+,41+,42+,43+,44+,45+,47+,48+,49+/m1/s1 InChIKey: FFBBHLKDMHCFTH-AKYHLAPZSA-N Opioid peptide according to the BIOPEP database of bioactive peptides (ID 2570) PepBank database Bitter peptide according to the BIOPEP database of sensory peptides and amino acids (ID 404)
Evidence 3 Activity

Activity

Blood-Brain Barrier
4.4 Counts

Assay & Model

Initial concentration in donor chamber-Culture
Area

Source & Reference

NA
B3Pdb

Other

Hemoglobin
Permeability
Evidence 4 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Opioid
Additional Detail Fields 2 fields
Opioid
9